Skip to main content
. Author manuscript; available in PMC: 2014 Jan 20.
Published in final edited form as: Neuroscience. 2010 May 8;169(2):706–719. doi: 10.1016/j.neuroscience.2010.05.008

Fig. 7.

Fig. 7

Top panel: A. Potentiated hyperglycemic response to TRH analog RX77368 (150 pmol) microinjected into the RVLM in GK rats compared to Wistar rats (data of the Wistar rats are adapted from Fig. 2). B, Unchanged blood glucose levels after RX77368 (150 pmol) microinjected into the nucleus ambiguus (Amb) in Wistar and GK rats. Each point represents mean ± SEM of the number of rats indicated near the line. * P < 0.05 compared with the value of the same time point in Wistar rats. # P< 0.05 compared with the basal levels of the same group. Lower panel: Coronal sections showing the microinjection sites in the RVLM (A) and Amb (B). Black circles are the microinjection sites in Wistar rats and the gray circles are those in GK rats.